Sierra Oncology, Inc.
https://www.sierraoncology.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sierra Oncology, Inc.
US FDA Pushes Back GSK’s Momelotinib Decision
GSK remains confident of approval despite the delay, with hopes of blockbuster sales for its myelofibrosis candidate.
Sobi Set To Grow Hematology Franchise With $1.7bn CTI Biopharma Buy
Sobi plans to capitalize on the complimentary expertise at CTI Biopharma to together boost sales of the latter firm’s myelofibrosis drug Vonjo and enhance the Swedish pharma firm’s overall growth.
10 Approvals To Look Out For In Q2
The second quarter has already seen the approval of Gamida Cell’s cell therapy Omisirge, and with the help of Biomedtracker, Scrip highlights 10 of the more interesting new drug approvals due in the next three months.
GSK Sees Blockbuster Chronic Cough Opportunity With $2bn Bellus Buyout
GSK has unveiled another targeted acquisition – of Bellus – that it hopes will bolster its presence in specialist respiratory medicine.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
-
Drug Delivery
- Macromolecule
-
Biotechnology
- Antisense, Oligonucleotides
- Drug Discovery Tools
- Large Molecule
- Liposomes
- Other Names / Subsidiaries
-
- ProNAi Therapeutics, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice